Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,602.00
Bid: 1,601.50
Ask: 1,602.00
Change: -164.50 (-9.31%)
Spread: 0.50 (0.031%)
Open: 1,616.50
High: 1,620.00
Low: 1,589.50
Prev. Close: 1,766.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK WINNERS & LOSERS SUMMARY: Pharmaceutical Firms Rally

Wed, 04th Nov 2020 10:38

(Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Wednesday.

----------

FTSE 100 - WINNERS

----------

AstraZeneca, up 4.3%, Hikma, up 4.0% and GlaxoSmithKline, 2.6% higher. Pharmaceutical firms, often touted as defensive stocks, were on the up early on Wednesday following a volatile start for the FTSE 100 amid a tight and hard-to-call US election result. A "blue wave" sweep by Democrats might have brought more regulation for the pharmaceutical industry.

----------

FTSE 100 - LOSERS

----------

HSBC and Standard Chartered, down 3.4% and 5.2%. The two banking stocks were at the FTSE 100 on Wednesday morning, amid the political tensions in the US, giving back gains from Tuesday when they closed 4.3% higher and 3.9% higher, respectively.

----------

FTSE 250 - WINNERS

----------

Royal Mail, up 8.0%. The postal service provider surged after JPMorgan raised the stock to Overweight from Neutral.

----------

Marks & Spencer, up 4.8%. The retailer's interim performance was better than expected, despite swinging to a pretax loss of GBP87.6 million from a GBP158.8 million profit. Revenue for the six months to September declined 16% to GBP4.09 billion from GBP4.86 billion a year before.

----------

OTHER MAIN MARKET AND AIM - WINNERS

----------

Stobart Group, up 9.4%. The logistics, energy and aviation firm was hit by a reduction in passenger travel at Southend Airport. Revenue in the six months ended August dropped 29% to GBP53.2 million from GBP74.8 million, and Stobart's pretax loss ballooned to GBP77.4 million from GBP15.5 million. The company however, affirmed that it "remains focused on exiting Stobart Air" and is in talks with parties to dispose of its stake.

----------

Wishbone Gold, up 70%. The exploration firm said that geological consultants Terra Search spotted four magnetic targets, covering a total of 2.4 kilometres by 400 metres, at the Patersons Range gold project in Australia. Wishbone added that it has completed due diligence to acquire the project and will now move towards closing the acquisition.

----------

Gattaca, up 37%. The engineering and technology recruitment services firm said revenue slipped 15% in the year ended July 31 to GBP538.7 million from GBP634.3 million. Pretax profit fell 57% to GBP1.4 million from GBP3.4 million. But notes it will carry out an improvement plan which will see its Technology unit restructured. Adds that it will deliver GBP4 million in annual savings from costs during the year to November.

----------

CPL Resources, up 34% to 951.50 pence. The Dublin-based human resources firm has accepted a EUR317.8 million takeover from Outsourcing, a Tokyo-listed HR services provider. The EUR11.25 per share offer is a 36% premium to CPL closing price on Tuesday.

----------

OTHER MAIN MARKET AND AIM - LOSERS

----------

Tern, down 10%. The internet of things-focused investor announced a GBP860,000 investment to take a 23% stake in Talking Medicines, a provider of AI and machine learning services to the pharmaceutical industry.

----------

By Eric Cunha; ericcunha@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
25 Oct 2023 07:27

GSK hails success in US RSV vaccine trial

(Sharecast News) - Pharma giant GSK has announced positive preliminary results from a trial of its Arexvy vaccine to treatment respiratory syncytial virus (RSV) disease for a younger patient population in the US.

Read more
16 Oct 2023 08:09

TOP NEWS: GSK receives positive EU opinion on Jemperli for cancer

(Alliance News) - GSK PLC on Monday said its monoclonal antibody Jemperli is closer to becoming the first new frontline treatment option in the EU in decades for a certain form of endometrial cancer.

Read more
16 Oct 2023 07:44

LONDON BRIEFING: Hipgnosis pulls interim dividend on lower royalties

(Alliance News) - The FTSE 100 is likely to open higher on Monday, benefitting from higher oil and gas prices, while fears of escalating regional conflict in the Middle East damp risk sentiment elsewhere.

Read more
16 Oct 2023 07:16

GSK nears green light for Jemperli usage in Europe

(Sharecast News) - Pharma giant GSK has announced that European experts recommended the approval of its Jerperli drug for the treatment of a specific type of endometrial cancer - paving the way for marketing authorisation by the continent's regulatory body.

Read more
11 Oct 2023 11:51

GSK settles California Zantac lawsuit

(Sharecast News) - GSK has agreed to settle another lawsuit concerning its discontinued heartburn treatment Zantac, the drugs giant confirmed on Wednesday.

Read more
11 Oct 2023 09:17

LONDON BROKER RATINGS: JPMorgan raises Croda; Berenberg cuts Atalaya

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning:

Read more
11 Oct 2023 08:51

LONDON MARKET OPEN: FTSE 100 higher; Travis Perkins warns on profit

(Alliance News) - Stock prices in London opened largely higher on Wednesday as market mood remained resilient, despite the continuing conflict in the Middle East, amid a softening of rhetoric from the US central bank.

Read more
11 Oct 2023 08:36

TOP NEWS: GSK reaches settlement for Zantac litigation in California

(Alliance News) - GSK PLC on Wednesday said that it has reached a confidential settlement in the Cantlay/Harper case, which alleged that the firm's heartburn medication can cause cancer.

Read more
11 Oct 2023 07:47

LONDON BRIEFING: Stocks lower; GSK settles Zantac case in California

(Alliance News) - Stocks in London are set to open lower on Wednesday as investor looked ahead to the release of the US Federal Reserve's September meeting minutes later in the day.

Read more
9 Oct 2023 08:16

TOP NEWS: GSK inks agreement with Zhifei to promote shingles vaccine

(Alliance News) - GSK PLC on Monday said it has reached an exclusive agreement with Chongqing Zhifei Biological Products Ltd to co-promote its shingles vaccine, Shingrix, in China.

Read more
9 Oct 2023 07:42

LONDON BRIEFING: Metro Bank secures deal to shore up finances

(Alliance News) - Stocks in London are set to open higher on Monday as interest rate expectations held steady despite Friday's bumper US nonfarm payrolls report.

Read more
9 Oct 2023 07:20

GSK inks deal to promote shingles vaccine in China

(Sharecast News) - GSK has entered into a new exclusive vaccine partnership in China that will extend the availability of its shingle vaccine Shingrix, which will see the UK-listed group generate £2.5bn over the next three years.

Read more
8 Oct 2023 11:36

Sunday newspaper round-up: Renewi, Metro Bank, New homes

(Sharecast News) - Some of Renewi's major shareholders are divided as to whether the recycling company should engage with Australian suitor Macquarie. One major shareholder has told Renewi's board that it should not until Macquarie raised its £636m bid, but another top ten shareholder told The Sunday Times that it should talk to the Australian outfit anyways. Macquarie has until 26 October to make a firm offer. - The Sunday Times

Read more
6 Oct 2023 08:17

GSK raises £885.6m from Haleon share sale

(Sharecast News) - GSK said on Friday that it has sold 270m shares in Haleon - the consumer health business it spun off last year - raising around £885.6m.

Read more
6 Oct 2023 07:57

UPDATE: GSK banks GBP886 million from Haleon share sale

(Alliance News) - GSK PLC on Friday said it received GBP885.6 million in gross proceeds from its sale of shares in consumer healthcare spin-off Haleon PLC.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.